Irritable Bowel Syndrome Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global irritable bowel syndrome treatment market size reached US$ 2.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.8 Billion by 2027, exhibiting a growth rate (CAGR) of 9.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Irritable bowel syndrome (IBS) refers to a chronic medical condition that affects the large intestine. It is usually caused by severe infection, stressful lifestyle, changes in gut microbes, muscle contractions in the intestine, and abnormalities in the nervous system. It can be characterized by gas, diarrhea, cramping, bloating, constipation, weight loss, vomiting, abdominal pain, and difficulty in swallowing. Several medications are currently available to relieve mild symptoms of IBS, including rifaximin, loperamide, laxatives, antispasmodics, fiber supplements, and coated peppermint oil capsules. Doctors also recommend probiotics and mental health therapies, such as cognitive behavioral-therapy (CBT), gut-directed hypnotherapy, and relaxation training, to treat certain patients.
Irritable Bowel Syndrome Treatment Market Trends:
Several factors increase the risk of IBS diseases, including food intolerances or sensitivities, bacterial infections in the digestive tract, small intestinal bacterial overgrowth, and mental disorders like anxiety, depression, and somatic symptom. This, along with improving diagnostic modalities and easy access to healthcare services, represents one of the key factors bolstering the growth of the market. Furthermore, IBS is one of the most common functional gastrointestinal disorders among the elderly. In confluence with this, the rising geriatric population across the globe is influencing the market positively. Besides this, several clinical trials, such as fecal microbiota transplantation (FMT), are being conducted to improve the treatment of IBS, which is contributing to market growth. In addition to this, as part of the Sustainable Development Goals (SDGs), governing agencies of various countries have pledged to substantially increase spending on research and development (R&D) projects and the number of researchers by 2030. This, in turn, is projected to expand the number of potential treatment options for IBS in the future.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global irritable bowel syndrome treatment market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, product and distribution channel.
Breakup by Type:
IBS with Diarrhea (IBS-D)
IBS with Constipation (IBS-C)
Mixed IBS
Breakup by Product:
Rifaximin
Eluxadoline
Lubiprostone
Linaclotide
Others
Breakup by Distribution Channel:
Hospitals Pharmacies
Drug Stores and Retail Pharmacies
Online Stores
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Allergan plc (AbbVie Inc.), Ardelyx Inc., Astellas Pharma Inc., AstraZeneca plc, Bausch Health Companies Inc., GlaxoSmithKline Plc, Novartis AG, Sebela Pharmaceuticals Inc., Synthetic Biologics Inc. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report:
How has the global irritable bowel syndrome treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global irritable bowel syndrome treatment market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global irritable bowel syndrome treatment market and who are the key players?
What is the degree of competition in the industry?
Irritable bowel syndrome (IBS) refers to a chronic medical condition that affects the large intestine. It is usually caused by severe infection, stressful lifestyle, changes in gut microbes, muscle contractions in the intestine, and abnormalities in the nervous system. It can be characterized by gas, diarrhea, cramping, bloating, constipation, weight loss, vomiting, abdominal pain, and difficulty in swallowing. Several medications are currently available to relieve mild symptoms of IBS, including rifaximin, loperamide, laxatives, antispasmodics, fiber supplements, and coated peppermint oil capsules. Doctors also recommend probiotics and mental health therapies, such as cognitive behavioral-therapy (CBT), gut-directed hypnotherapy, and relaxation training, to treat certain patients.
Irritable Bowel Syndrome Treatment Market Trends:
Several factors increase the risk of IBS diseases, including food intolerances or sensitivities, bacterial infections in the digestive tract, small intestinal bacterial overgrowth, and mental disorders like anxiety, depression, and somatic symptom. This, along with improving diagnostic modalities and easy access to healthcare services, represents one of the key factors bolstering the growth of the market. Furthermore, IBS is one of the most common functional gastrointestinal disorders among the elderly. In confluence with this, the rising geriatric population across the globe is influencing the market positively. Besides this, several clinical trials, such as fecal microbiota transplantation (FMT), are being conducted to improve the treatment of IBS, which is contributing to market growth. In addition to this, as part of the Sustainable Development Goals (SDGs), governing agencies of various countries have pledged to substantially increase spending on research and development (R&D) projects and the number of researchers by 2030. This, in turn, is projected to expand the number of potential treatment options for IBS in the future.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global irritable bowel syndrome treatment market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, product and distribution channel.
Breakup by Type:
IBS with Diarrhea (IBS-D)
IBS with Constipation (IBS-C)
Mixed IBS
Breakup by Product:
Rifaximin
Eluxadoline
Lubiprostone
Linaclotide
Others
Breakup by Distribution Channel:
Hospitals Pharmacies
Drug Stores and Retail Pharmacies
Online Stores
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Allergan plc (AbbVie Inc.), Ardelyx Inc., Astellas Pharma Inc., AstraZeneca plc, Bausch Health Companies Inc., GlaxoSmithKline Plc, Novartis AG, Sebela Pharmaceuticals Inc., Synthetic Biologics Inc. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report:
How has the global irritable bowel syndrome treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global irritable bowel syndrome treatment market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global irritable bowel syndrome treatment market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 IBS with Diarrhea (IBS-D)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 IBS with Constipation (IBS-C)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Mixed IBS
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY PRODUCT
7.1 Rifaximin
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Eluxadoline
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Lubiprostone
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Linaclotide
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Hospitals Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Stores and Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Allergan plc (AbbVie Inc.)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Ardelyx Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Astellas Pharma Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 AstraZeneca plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Bausch Health Companies Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 GlaxoSmithKline Plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Novartis AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sebela Pharmaceuticals Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Synthetic Biologics Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Takeda Pharmaceutical Company Limited
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 IBS with Diarrhea (IBS-D)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 IBS with Constipation (IBS-C)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Mixed IBS
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY PRODUCT
7.1 Rifaximin
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Eluxadoline
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Lubiprostone
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Linaclotide
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Hospitals Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Stores and Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Allergan plc (AbbVie Inc.)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Ardelyx Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Astellas Pharma Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 AstraZeneca plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Bausch Health Companies Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 GlaxoSmithKline Plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Novartis AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sebela Pharmaceuticals Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Synthetic Biologics Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Takeda Pharmaceutical Company Limited
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Irritable Bowel Syndrome Treatment Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 4: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Irritable Bowel Syndrome Treatment Market: Competitive Structure
Table 7: Global: Irritable Bowel Syndrome Treatment Market: Key Players
Table 1: Global: Irritable Bowel Syndrome Treatment Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 4: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Irritable Bowel Syndrome Treatment Market: Competitive Structure
Table 7: Global: Irritable Bowel Syndrome Treatment Market: Key Players
LIST OF FIGURES
Figure 1: Global: Irritable Bowel Syndrome Treatment Market: Major Drivers and Challenges
Figure 2: Global: Irritable Bowel Syndrome Treatment Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Type (in %), 2021
Figure 5: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Product (in %), 2021
Figure 6: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Region (in %), 2021
Figure 8: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Irritable Bowel Syndrome Treatment (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Irritable Bowel Syndrome Treatment (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Irritable Bowel Syndrome Treatment Industry: SWOT Analysis
Figure 80: Global: Irritable Bowel Syndrome Treatment Industry: Value Chain Analysis
Figure 81: Global: Irritable Bowel Syndrome Treatment Industry: Porter's Five Forces Analysis
Figure 1: Global: Irritable Bowel Syndrome Treatment Market: Major Drivers and Challenges
Figure 2: Global: Irritable Bowel Syndrome Treatment Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Type (in %), 2021
Figure 5: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Product (in %), 2021
Figure 6: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Region (in %), 2021
Figure 8: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Irritable Bowel Syndrome Treatment (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Irritable Bowel Syndrome Treatment (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Irritable Bowel Syndrome Treatment Industry: SWOT Analysis
Figure 80: Global: Irritable Bowel Syndrome Treatment Industry: Value Chain Analysis
Figure 81: Global: Irritable Bowel Syndrome Treatment Industry: Porter's Five Forces Analysis
